Global Open-Angle Glaucoma API Manufacturers, Marketed and Phase III Drugs Landscape, 2015

on Tuesday, 17 March 2015 include new market research report " Global Open-Angle Glaucoma Market 2015: Industry Size, Shares, Growth, Analysis, Trends And Forecast" to its huge collection of research reports.

The Report gives insights into patents providing thepatent protection data and marketing exclusivity of all the drugs across the Open-Angle Glaucoma. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturersacross the globe coveringDrug Master FilingsofUS, Europe and API Manufacturers in Asia specifically China and India. The researchanalysis also presents the global sales forecasts data till 2016.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

  • A snapshot of the global Market therapeutics scenario for Open-Angle Glaucoma.
  • A review of the marketed products under prescription for Open-Angle Glaucoma, regulatory information and marketing status.
  • Coverage of global patent coverage and detailed commentaries on the US patent challenges.
  • Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
  • Product profiles for marketed products for Open-Angle Glaucoma with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
  • Coverage of API Manufacturers for Open-Angle Glaucoma drugs in the United States, Europe and Asian Regions with location details.
  • Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Open-Angle Glaucoma drugs.
  • Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Open-Angle Glaucoma drugs.
  • Coverage of Open-Angle Glaucoma Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
  • Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
  • Key discontinued Marketed products.
  • Global Sales Figure from 2012-2016.
Browse More reports related to Pharmaceuticals at:

  • Evaluate the marketing status and exclusivity details of Open-Angle Glaucomakey products to exploit opportunities for generic drug development opportunities.
  • Identify and understand important and diverse types of therapeutics under Phase III development for Open-Angle Glaucoma.
  • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Open-Angle Glaucoma.
  • API intelligence over marketed drugs forOpen-Angle Glaucomaand gaining primary intelligence over active ingredients manufacturers across the globe.
  • API intelligence over leading Phase III Pipeline drugs.
  • Develop and designstrategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.
  • Understanding the scope of the Phase III Drugs with nil regulatory filings.
  • Understanding the chemical route of synthesis of approved drugs for Open-Angle Glaucoma.
  • Uncovering opportunities in the rapidly growing US market.

About Us:

ResearchMoz ( ) is the one stop online destination to find and buy market research reports. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. We provide the market context, competitor insight and future trends needed for strategic planning.

For More Information Kindly Contact: 
Mr. Nachiket
Toll Free: 866-997-4948


Post a Comment